Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open-label study

BACKGROUND: The effect of IL-1 blocking therapy on mucocutaneous manifestations of Behçet’s disease is incompletely understood. METHODS: Six patients with Behçet’s disease and ongoing oral/genital ulcers for ≥1 month were enrolled into an adaptive, two-phase clinical trial and included in the analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayson, Peter C., Yazici, Yusuf, Merideth, Melissa, Sen, H. Nida, Davis, Michael, Novakovich, Elaine, Joyal, Elizabeth, Goldbach-Mansky, Raphaela, Sibley, Cailin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364674/
https://www.ncbi.nlm.nih.gov/pubmed/28335798
http://dx.doi.org/10.1186/s13075-017-1222-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364674/
https://www.ncbi.nlm.nih.gov/pubmed/28335798
http://dx.doi.org/10.1186/s13075-017-1222-3

Ejemplares similares